Search Site

ADNOC Drilling closes JV

It is a JV between ADNOC Drilling, SLB and Patterson UTI.

Boeing to boost 787 production

The firm will invest$1bn to ramp up production in South Carolina.

ADNOC signs deal with PETRONAS

Under the agreement, ADNOC will supply 1m tons of LNG per year.

Aramco-Horse Powertrain deal completed

An agreement for the purchase of 10% equity stake was signed in June 2024.

Roche to buy Poseida Therapeutics

The $1.5 billion deal is due to close in early 2025.

Fertiglobe Q3 revenue of $525m

The transaction supports Fertiglobe's future growth plans. (WAM)
  • In the third quarter, nitrogen prices reflected tighter market balances due to record low inventory levels.
  • In the medium to longer term, the nitrogen outlook is favorable, with limited supply additions over the next several years.

ABU DHABI, UAE – Fertiglobe, the strategic partnership between ADNOC and OCI Global, on Tuesday reported Q3 2023 revenues of $525 million, adjusted EBITDA of $199 million, adjusted net profit of $41 million, and free cash flows of $126 million.

Sales volumes rose by 8 percent for the third quarter relative to the same period last year, driven by 10 percent higher urea sales volumes.

For the nine months ended September 30  2023, the company reported revenues of $1.8 billion, adjusted EBITDA of $715 million, adjusted net profit of $261 million, and free cash flows of $458 million.

Fertiglobe’s board of directors approved dividends of $275 million for H1 2023, equivalent to 12 fils/share.

The company’s healthy free cash flow conversion and strong balance sheet (net cash position of $28 million or 0.0x net leverage / LTM adjusted EBITDA as of September 30 2023) enable it to maintain dividend payments while investing in value accretive growth projects.

Ahmed El-Hoshy, CEO of Fertiglobe, said, “Despite the traditional summer lull for fertilizer sales, we saw nitrogen prices maintain their positive momentum in Q3, driven by tightening markets on planned and unplanned supply disruptions, restocking demand, as well as expectations of reduced exports from China.”

He said, “Nitrogen prices have increased significantly from their troughs in the second and third quarters, and we expect the benefits from these increases to materialize in the fourth quarter.”

The short-term outlook is further underpinned by a strong order book for ammonia and urea sales in Q4 2023.

In the medium to longer term, the nitrogen outlook remains favorable, with limited incremental supply additions over the next several years, healthy farm economics and elevated energy prices raising marginal cost floors, particularly going into winter.

The expected recovery in demand ahead of the spring application season in the Northern Hemisphere should continue to support prices going in Q4 2023, and Fertiglobe remains ideally positioned to serve key import markets.

In the third quarter, nitrogen prices reflected tighter market balances due to record low inventory levels, healthy demand from crucial importing regions, restrictions on Chinese urea exports and supply disruptions.

El-Hoshy said, “Alongside ADNOC, we recently announced the pilot deployment of the world’s first modular CycloneCC carbon capture unit at our Fertil plant in the UAE, with the potential for broader deployment across our operations, if successful.”

He said, “We are committed to leveraging our state-of-the-art ammonia facilities and global distribution infrastructure to expand our low-carbon ammonia capacity as part of our commitment to reducing the carbon footprint of our operations and meeting increasing demand for low-carbon hydrogen and ammonia.”

Fertiglobe has recently launched initiatives to further optimize its cost structure and reinforce its top quartile cash cost positioning, targeting $50 million in recurring annualized savings by the end of 2024.

Key focus areas include enhancements to the operating model, improvements in logistical capabilities and increased capex and opex efficiencies.

Meanwhile, Fertiglobe’s manufacturing improvement plan remains on track to deliver further operational and cost efficiencies between 2023 and 2025.

Following quarter-end, Fertiglobe has reached a commercial agreement with a group of its core relationship banks on the terms of a new $500 million term facility, which is expected to be executed shortly.

Once the facility is executed, the proceeds will be used to refinance shorter-term borrowings, further improving Fertiglobe’s maturity profile and liquidity in line with the company’s commitment to an investment-grade capital structure.

As of September 30 2023, Fertiglobe reported a net cash position of $28 million, compared to a net cash position of $287 million as of December 31 2022, allowing it to continue balancing the pursuit of future growth opportunities with an attractive dividend pay-out.

Fertiglobe announced the board of directors’ approval of H1 2023 dividends at $275 million, equivalent to 12 fils per share, payable in the next few weeks.